A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis.

Ei ShiomiYuta GotoMizuki HisanoRento ItoMakoto MoriwakaDaiki Ikarashi Shigekatsu MaekawaRenpei KatoMitsugu KanehiraTakashi UjiieWataru Obara

Published in: IJU case reports (2024)

A complete response was achieved after Ave plus Axi combination therapy for clear cell renal cell carcinoma in a patient undergoing dialysis. This suggests that Ave plus Axi combination therapy may be safe and effective for dialysis patients.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
combination therapy
squamous cell carcinoma
small cell lung cancer
newly diagnosed
ejection fraction
patient reported outcomes
patient reported